Many Women Bypass Nearest Hospital for Breast Cancer Surgery
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Jan. 8, 2024 -- Many women undergoing breast-conserving surgery (BCS) or mastectomy bypass their nearest hospitals, according to a study published online Jan. 8 in Cancer.
Ajay Aggarwal, M.D., Ph.D., from the London School of Hygiene and Tropical Medicine, and colleagues used linked administrative datasets from the English National Health Service to identify all women who underwent BCS or mastectomy with or without immediate breast reconstruction. A geographic information system was used to examine the extent to which patients bypassed their nearest hospital.
The researchers found that 32.7 percent of the 69,153 patients undergoing BCS and 30.5 percent of the 23,536 patients undergoing mastectomy bypassed their nearest hospital. The likelihood of traveling to more distant hospitals was increased for women who were younger, who had no comorbidities, and were from rural areas. Despite not undergoing reconstruction, women undergoing BCS or mastectomy were more likely to be treated at specialist breast reconstruction centers (odds ratios, 1.85 and 1.52, respectively). The likelihood of traveling to hospitals employing surgeons who had a media reputation was increased for patients receiving mastectomy and immediate breast reconstruction (odds ratio, 2.41). The likelihood of traveling to hospitals with shorter waiting time was lower for patients undergoing BCS (odds ratio, 0.65).
"Patients seem to be influenced by the reputation of hospitals and their surgeons, particularly those performing advanced breast‐reconstruction techniques," the authors write. "This highlights that policies offering patients with breast cancer the opportunity to choose where they have their treatment may drive inequalities in the health care system without necessarily improving patient outcomes."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-09 04:15
Read more
- 1 in 5 Americans' Drinking Water Tainted With PFAS Chemicals
- IDSA: EHR Order Set Reduces Antibiotic Duration in Children With AOM
- Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with Keytruda (pembrolizumab) After Neoadjuvant Keytruda and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
- Neurogene Reports Positive Interim Efficacy Data from First Four Low-Dose Pediatric Participants in NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
- UCB Receives U.S. FDA Approval for 320 mg Single-Injection Device Presentations of Bimzelx (bimekizumab-bkzx)
- AI Might Help Pick Up Heart Trouble in Dogs
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions